CClinicalTrials.gg
RecruitingNCT07279701PEDVEINUpdated Feb 27, 2026

The Effect of Near-infrared Spectroscopy on the Success of Peripheral Venous Access

An interventional study of Use of near-infrared imaging by VeinViewer Flex of periferal veins in Intravenous Cannulation, sponsored by Brno University Hospital. Recruiting at 1 site in Czechia. Open to participants aged 0 Days to 19 Years. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by Brno University Hospital · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
0 Days to 19 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if using near-infrared imaging in pediatric vein cannulation is leading to higher success rate. The main question it aims to answer is:

is there higher success of first attempt in periferal vein cannulation? does it lower overall number of attempts to successful cannulation?

Read the detailed description

Providing venous access in pediatric anesthesia and intensive care is among the basic and necessary interventions for blood sampling and administration of drugs and possibly transfusion products and derivatives.

In anesthesia, effective provision of venous access is a prerequisite for safe anesthesia. In pediatric patients and newborns, provision of venous access is complicated by patient non-cooperation, but primarily by the smaller diameter of the vessels and often limited possibility of direct visualization, or limited possibility of palpation of the vessel under visual control. Ultrasound is currently used to facilitate provision of IV access, however, imaging under the USG probe and its subsequent puncture requires high skill of medical personnel and is preferentially applied by medical staff in the conditions of the Czech Republic. Near-infrared imaging (IR) allows direct visualization of superficial vascular bed and may potentially be associated with higher puncture success rates (higher first attempt success, reduction of total attempts).

02

Conditions studied

  • Intravenous Cannulation

Keywords

  • pediatric
  • near-infrared imaging
  • periferal vein cannulation
  • difficult intravenous access
03

Who can participate

Ages eligible
0 Days to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pediatric patients admitted to the inpatient section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital
  • Pediatric patients in the anesthesia section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital
  • Indicated insertion of peripheral venous access
  • Consent of the patient/legal representative to the study

Exclusion criteria

Exclusion Criteria:

  • Disagreement with the study
  • Not indicated insertion of peripheral venous access (according to clinical condition and decision of the attending physician)
  • A device for near-infrared imaging of the venous bed is not available
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    VeinViewer Flex

    The periferal vein cannulation will be aided by concurrent near-infrared imaging by device VeinViewer Flex using AVIN™ (Active Vascular Imaging Navigation).

    Device: Use of near-infrared imaging by VeinViewer Flex of periferal veins

  • No intervention
    Landmark

    The peripheral vein cannulatoon will be provided by usual landmark technique, without any other imaging device.

Interventions

  • DeviceUse of near-infrared imaging by VeinViewer Flex of periferal veins

    The projected near-infrared light is absorbed by the blood and reflected by surrounding tissue, captured, processed, and digitally projected in real time directly onto the skin surface. It provides an accurate, real-time image of the patient's blood pattern. Patented VeinViewer technology using AVIN™ (Active Vascular Imaging Navigation) allows the blood vessels to be seen down to a depth of 10 mm. With VeinViewer, physicians can see peripheral veins, bifurcations, and valves and assess venous filling/flushing in real time.

05

What researchers measure

Primary outcomes

  1. Success rate of first attempt in peripheral vein cannulation

    Success rate of first attempt in periferal vein cannulation

    Time frame: Periprocedural

  2. Number of attempts

    Overall number of attempts needed to secure periferal vein access

    Time frame: Periprocedural

06

Study locations

1 of 1 sites recruiting
  • University Hospital Brno
    Brno, South Moravian 60200, Czechia
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07279701
Lead sponsor
Brno University Hospital
Responsible party
Petr Štourač, MD (prof. MD, PhD, Brno University Hospital) — Principal investigator
First posted
Dec 12, 2025
Start date
Dec 15, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Feb 27, 2026

Study contacts

Hana Harazim, MD, PhD
Contact
harazim.hana@fnbrno.cz
+420777146704
Petr Štourač, prof, MD, PhD
principal investigator · Brno University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion